Hem › Glioblastom › Kalifornien › Sacramento
Kliniska studier för Glioblastom i Sacramento, CA
4 studier för Glioblastom söker deltagare vid platser i och runt Sacramento (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
RekryterarFas 1/2
- University of California Davis Comprehensive Cancer Center, Sacramento
Laser Interstitial Thermal Therapy (LITT) and Lomustine (CCNU) for Recurrent Glioblastoma
RekryterarFas 1
- University of California Davis Comprehensive Cancer Center, Sacramento
Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma
RekryterarFas 3
- University of California Davis Comprehensive Cancer Center, Sacramento
Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
RekryterarFas 1
- University of California Davis Comprehensive Cancer Center, Sacramento
Glioblastom-studier i andra städer
- New York City, NY30 studier
- Boston, MA28 studier
- Houston, TX26 studier
- Los Angeles, CA24 studier
- Durham, NC20 studier
- San Francisco, CA17 studier
- Chicago, IL15 studier
- Washington, DC15 studier
- Columbus, OH14 studier
- Miami, FL14 studier
- Rochester, MN13 studier
- Jacksonville, FL13 studier
Andra studier i Sacramento
- Icke-småcellig lungcancer29 studier
- Lungcancer22 studier
- Bröstcancer20 studier
- Prostatacancer19 studier
- Metastaserande cancer16 studier
- Akut myeloid leukemi12 studier
- Hjärtsvikt12 studier
- Bukspottkörtelcancer12 studier
- Cancer (alla typer)11 studier
- Tjocktarmscancer11 studier
- Blåscancer10 studier
- Kolorektal cancer10 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.